Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1999
11/02/1999US5977185 Method for prevention and treatment of production disease of genetically improved livestock and poultry
11/02/1999US5977163 Water soluble paclitaxel prodrugs
11/02/1999US5977161 Kappa-opiate agonists effective in the treatment of postoperative ileus
11/02/1999US5977154 Obesity, diabetes
11/02/1999US5977151 Isoxazole and crotonamide derivatives and their use as pharmaceuticals and diagnostics
11/02/1999US5977150 Amino acid derivatives of diaryl 1,3,4-oxadiazolone
11/02/1999US5977144 Methods of use and compositions for benzylidene- and cinnamylidene-anabaseines
11/02/1999US5977135 Bicyclic heterocycles
11/02/1999US5977131 Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
11/02/1999US5977129 Alzheimer's disease
11/02/1999US5977126 Antiangrogens, enzyme inhbitors
11/02/1999US5977122 Antiinflammatory, antiallergens, tumor necorsis factor inhibitor
11/02/1999US5977119 Trisubstituted thioxanthines
11/02/1999US5977108 Leukemia
11/02/1999US5977107 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
11/02/1999US5977106 3,5-dioxo-(2H,4H)-1,2,4-triazine derivatives
11/02/1999US5977103 Substituted imidazole compounds
11/02/1999US5977102 Inhibitory effect on signal transduction mediated by tyrosine kinases or epidermal growth factor; antitumor,-carcinogenic, -metastasis,-proliferation agents and -inflammatory agents; psoriasis; angiogenesis inhibitors; immunology;
11/02/1999US5977099 Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
11/02/1999US5977098 Benzo[B]thiophene compounds, intermediates, processes, compositions, and methods
11/02/1999US5977095 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and respiratory distress syndrome
11/02/1999US5977094 Methods and compositions using Δ16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors
11/02/1999US5977092 Drug for curing/ameliorating concomitant syndrome of tumor
11/02/1999US5977084 Self-assembling polynucleotide delivery method
11/02/1999US5977081 Triterpene saponin analogs having adjuvant and immunostimulatory activity
11/02/1999US5977075 N-aroylamino acid amides as endothelin inhibitors
11/02/1999US5977071 Complexes; antidiabetic agent
11/02/1999US5977059 Therapeutic system for dietary health management
11/02/1999US5976838 Secreted proteins and polynucleotides encoding them
11/02/1999US5976834 cDNA clone HNFJD15 that encodes a novel human 7-transmembrane receptor
11/02/1999US5976597 Basic protein composition, basic peptide composition and application thereof
11/02/1999US5976558 Silicone-containing derivatives of salicylic acid which have desquamating properties
11/02/1999US5976534 Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
11/02/1999CA2161542C Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives
10/1999
10/28/1999WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999WO1999054706A2 Method of treating interstitial cystitis with recombinant hb-egf
10/28/1999WO1999054481A1 Mutant having uracil phosphoribosyl transferase activity
10/28/1999WO1999054469A1 B-cell growth factor related protein
10/28/1999WO1999054468A1 Soluble protein ztmpo-1
10/28/1999WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999WO1999054463A2 Human k+ ion channel and therapeutic applications thereof
10/28/1999WO1999054445A2 Combination therapy using nucleic acids and conventional drugs
10/28/1999WO1999054359A1 Matrix binding factor
10/28/1999WO1999054351A1 Edg family gene, human h218
10/28/1999WO1999054350A1 Novel omega conotoxin peptides
10/28/1999WO1999054341A1 Enhanced antisense modulation of icam-1
10/28/1999WO1999054336A1 (alpha-aminophosphino) peptidesderivative and compositions containing same
10/28/1999WO1999054333A1 Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction
10/28/1999WO1999054331A1 Novel asymmetrically substituted xanthine derivatives, method for producing them and their use as medicaments with an adenosine-antagonistic effect
10/28/1999WO1999054320A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
10/28/1999WO1999054311A1 Novel diphenyl-substituted 6-ring-heterocycles, methods for producing them and their use as medicaments
10/28/1999WO1999054310A2 New substituted amides, their production and their use
10/28/1999WO1999054309A1 Naphthalene derivatives, their production and use
10/28/1999WO1999054308A1 5-aminoindeno(1,2-c)pyrazol-4-ones as anti-cancer and anti-proliferative agents
10/28/1999WO1999054305A1 Heterocyclically substituted amides used as calpain inhibitors
10/28/1999WO1999054304A1 Heterocyclically substituted amides, their production and their use
10/28/1999WO1999054299A1 Pyrrolidines as inhibitors of neuraminidases
10/28/1999WO1999054294A1 New substituted amides, their production and their use
10/28/1999WO1999054293A1 Substituted benzamides, their production and their use as cysteine protease inhibitors
10/28/1999WO1999054290A1 Inhibitors of neuraminidases
10/28/1999WO1999054286A2 Btk inhibitors and methods for their identification and use
10/28/1999WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999WO1999053946A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999WO1999053944A1 Method for treating the endotoxic shock in mammals
10/28/1999WO1999053943A2 Therapeutic angiogenic factors and methods for their use
10/28/1999WO1999053934A1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis
10/28/1999WO1999053932A1 Streptococcus preparation
10/28/1999WO1999053928A1 Treatment of iatrogenic and age-related hypertension and pharmaceutical compositions useful therein
10/28/1999WO1999053921A1 Composition comprising l-carnitine or an alkanoyl l-carnitine and nadh and/or nadph
10/28/1999WO1999053920A1 Use of vitamin pp compounds
10/28/1999WO1999053917A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999WO1999053912A1 Topical immunostimulation to induce langerhans cell migration
10/28/1999WO1999053910A2 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems
10/28/1999WO1999053901A1 Pharmaceutical aerosol formulation
10/28/1999WO1999043654A3 Inhibitors of phospholipase enzymes
10/28/1999WO1999042127A3 Receptor derived peptides as modulators of receptor activity
10/28/1999WO1999042089A9 Use of thiadiazolo[4,3-a]pyridine derivatives
10/28/1999WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999WO1999037299B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/28/1999WO1999035243A9 Extension of cellular lifespan, methods and reagents
10/28/1999WO1999033858A9 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use
10/28/1999WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999WO1999021540B1 Method of reducing craving in mammals
10/28/1999WO1999004773A9 Method for inhibiting bone resorption
10/28/1999WO1998044104A3 Flip gene and flip protein
10/28/1999WO1998040099A9 Leptospira pathogens
10/28/1999WO1997029739A3 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
10/28/1999DE19818044A1 Reducing side effects or neutralizing action of carcinostatic or immunosuppressive agents, especially pyridine derivatives, using vitamin PP compounds, e.g. nicotinamide
10/28/1999CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999CA2329660A1 Inhibitors of neuraminidases
10/28/1999CA2329637A1 (alpha-aminophosphino) peptidesderivative and compositions containing same
10/28/1999CA2329626A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999CA2329422A1 Pyrrolidines as inhibitors of neuraminidases
10/28/1999CA2329302A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999CA2329010A1 Therapeutic angiogenic factors and methods for their use
10/28/1999CA2328973A1 Naphthalene derivatives, their production and use
10/28/1999CA2328962A1 Btk inhibitors and methods for their identification and use
10/28/1999CA2328882A1 Pharmaceutical aerosol formulation
10/28/1999CA2328774A1 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf)
10/28/1999CA2328720A1 Novel heterocyclically substituted amides with cysteine protease-inhibiting effect
1 ... 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 ... 1564